 Chemotherapy radiation therapy anal carcinoma Survival late morbidity study survival late morbidity rates chemotherapy radiation therapy regimen patients carcinoma anal canal patients radiation therapy cGy anteroposterior-posteroanterior AP-PA fields chemotherapy mitomycin Patients primary tumors complete response rate survival rate significant difference survival rate tumor stage Patients local recurrence primary surgery complete response rate survival rate Fifteen percent patients late treatment-related symptoms anal incontinence intestinal obstruction chronic pelvic pain current treatment regimen effective considerable risk complications survival rate independent tumor stage locoregional treatment extensive small tumors advanced tumors strategy late side effects patients small tumors survival rate